Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...

Boeing's labor dispute has sent its stock to a 52-week low. JPMorgan Chase (NYSE ... and consistently hiking them remain appealing to income-focused investors. Gilead Sciences, Verizon Communications ...

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

“Our objective is to provide investors a list of stocks that may generate attractive returns on a long-term basis as the ...

20 January 2022 Gilead Sciences has sued an array of pharmaceutical suppliers and distributors accusing them of forming a ...

Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

As global markets rebound from recent sell-offs, with growth stocks notably outpacing value shares, the technology sector has ...

Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million ...

Inc. (GILD) stock to Outperform rating, as announced on July 8, 2024, according to Finviz. Earlier, on May 1, 2024, Maxim Group had reiterated the stock to Buy, setting a price target of $85. for GILD ...